Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses

Laura A. VanBlargan, John M. Errico, Natasha M. Kafai, Katherine E. Burgomaster, Prashant N. Jethva, Rebecca M. Broeckel, Kimberly Meade-White, Christopher A. Nelson, Sunny Himansu, David Wang, Scott A. Handley, Michael L. Gross, Sonja M. Best, Theodore C. Pierson, Daved H. Fremont, Michael S. Diamond

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Although Powassan virus (POWV) is an emerging tick-transmitted flavivirus that causes severe or fatal neuroinvasive disease in humans, medical countermeasures have not yet been developed. Here, we developed a panel of neutralizing anti-POWV mAbs recognizing six distinct antigenic sites. The most potent of these mAbs bind sites within domain II or III of the envelope (E) protein and inhibit postattachment viral entry steps. A subset of these mAbs cross-react with other flaviviruses. Both POWV type–specific and cross-reactive neutralizing mAbs confer protection in mice against POWV infection when given as prophylaxis or postexposure therapy. Several cross-reactive mAbs mapping to either domain II or III also protect in vivo against heterologous tick-transmitted flaviviruses including Langat and tick-borne encephalitis virus. Our experiments define structural and functional correlates of antibody protection against POWV infection and identify epitopes targeted by broadly neutralizing antibodies with therapeutic potential against multiple tick-borne flaviviruses.

Original languageEnglish
Article numbere20210174
JournalJournal of Experimental Medicine
Volume218
Issue number5
DOIs
StatePublished - Apr 8 2021

Fingerprint

Dive into the research topics of 'Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses'. Together they form a unique fingerprint.

Cite this